en

PRODUCT DETAIL

Lenalidomid Mylan 7,5 mg tvrdé kapsuly

Code 6303D
MA number EU/1/20/1490/008
Product Form: cps dur 21x1x7,5 mg (blis.PVC/Aclar/Al-jednotk.dávka)
MA Status: E - Valid centralised marketing authorisation
Type of procedure: EU
Therapeutic Class: 59 - IMMUNOPRAEPARATA
ATC:
L ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
L04 Immunosuppressants
L04A Immunosuppressants
L04AX Other immunosuppressants
L04AX04 Lenalidomide
Shelf life: 36
Container: blister PVC/Aclar/Al
Route of admin.: Oral use
Prescription Status: Medicinal product subject to restricted medical prescription.
Legal basis: Article 10(1) generic application
MA issued: 18.12.2020
Validity: 18.12.2025
SmPC + PL: European Medicines Agency's database
Safety feature Yes
Data update: 11.07.2023
eu-flag.png sk-flag.png